As of December 2024 Alnylam Pharmaceuticals has a market cap of ₹2.699 Trillion. This makes Alnylam Pharmaceuticals the world's 626th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 17th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be: